Single Cell Sequencing Market by Product (Reagents & Kits, Platforms, Software), Workflow (Presequencing), Service (Sample Preparation, Bioinformatics), Sequencing (scRNA, scDNA), Application (Research, Diagnostic), End User - Global Forecast to 2030

icon1
USD 3.46 BN
MARKET SIZE, 2030
icon2
CAGR 12.2%
(2025-2030)
icon3
622
REPORT PAGES
icon4
845
MARKET TABLES

OVERVIEW

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global single-cell sequencing market is expected to reach USD 3.46 billion by 2030 from USD 1.95 billion in 2025, at a CAGR of 12.2% during the forecast period of 2025–2030. Single-cell sequencing is a genomic technique that helps researchers study the genetic materials of individual cells, aiding in identifying differences between individual cells and offering a clear understanding of cellular functions, disease mechanisms, and treatment responses. The growth in this market is supported by ongoing advancements in single-cell workflow techniques and the growing demand for personalized medicines and biomarker discovery utilizing single-cell sequencing.

KEY TAKEAWAYS

  • The North America single-cell sequencing market dominated, with a share of 45.3% in 2024.
  • By offering, the products segment accounted for the largest market share of 75.3% in 2024.
  • By product type, the consumables segment is expected to register the highest CAGR of 11.4%.
  • Based on workflow, the pre-sequencing segment accounted for the largest share of the single-cell sequencing market.
  • By service type, the sequencing services segment will grow the fastest during the forecast period of 2025 to 2030.
  • By sequencing type, the scRNA seq segment dominated the market in 2024.
  • By application, the research applications segment accounted for the largest share of the single-cell sequencing market.
  • The end users of single-cell sequencing (SCS) products include academic & research institutions, pharmaceutical & biotechnology companies, hospitals & clinical laboratories, as well as contract research organizations (CROs). The academic & research institutions segment dominates the market.
  • By end users of single-cell sequencing (SCS) services, the pharmaceutical & biotechnology companies segment is anticipated to grow at fastest rate during the forecast period.
  • 10x Genomics, Inc., Illumina, Inc., BD, were identified as Star players in the single-cell sequencing products market, as they have focused on innovation and have broad industry coverage and strong operational & financial strength.
  • Precision Cell Systems (S2 Genomics, Inc.), BioSkryb Genomics, ScaleBio, have distinguished themselves among startups and SMEs due to their strong product/service portfolio and business strategy.

The single-cell sequencing (SCS) market is expected to experience significant growth, driven by advancements in single-cell techniques that support the increasing demand for personalized medicine and biomarker discovery applications. Additionally, the integration of artificial intelligence and machine learning (AI/ML) in data analysis not only reduces the cost of single-cell sequencing but also improves the technique's scalability, thereby lowering the barriers to adoption. Furthermore, major companies like Roche are developing advanced single-cell sequencing platforms (SBX) to address current challenges such as cost, accuracy, and throughput. This presents valuable growth opportunities within the SCS market.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The impact of technological advancements and emerging applications on consumers' businesses in the single-cell sequencing market is significant. Innovations such as advanced single-cell platforms, SBX technology, multi-omics integration, and AI-driven data analysis are generating new insights, promoting precision medicine, and expanding opportunities for sequencing technology providers.

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Advancements in single-cell sequencing technologies
  • Growing focus on precision medicine and biomarker discovery
RESTRAINTS
Impact
Level
  • High cost of single-cell sequencing products & services
OPPORTUNITIES
Impact
Level
  • Integration of multi-omics technologies
  • Emergence of SBX technology
CHALLENGES
Impact
Level
  • Complexities associated with high-dimensional single-cell data
  • Biological variability and cell heterogeneity

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Advancements in single-cell sequencing technologies

Recent advancements in single-cell sequencing (SCS) technologies are propelling market growth by providing higher resolution and the ability to capture cellular heterogeneity. These improvements lead to increased throughput and more accurate molecular profiling. As a result, SCS has become highly appealing for precision medicine, biomarker discovery, and drug development. Additionally, innovations such as SBX technology, multi-omics integration, and AI-driven data analysis enable researchers to gain deeper insights, achieve faster interpretations, and obtain more comprehensive characterizations of individual cells. These technological developments are broadening the application of SCS in areas such as cancer research, immunology, developmental biology, and clinical diagnostics, thereby creating new opportunities for researchers, healthcare providers, and sequencing technology companies.

Restraint: High cost of single-cell sequencing products & services

The growth of the single-cell sequencing (SCS) market is limited by the high costs associated with instruments, reagents, and services, which can be a barrier for smaller laboratories and research centers. In addition to the expensive equipment, specialized infrastructure and skilled personnel are often required, further increasing the overall expenses. These costs make it challenging for some institutions to adopt SCS, even though the technology provides valuable insights. Consequently, while single-cell sequencing is transforming research and diagnostics, its price remains a significant obstacle to wider adoption.

Opportunity: Integration of multi-omics technologies

The integration of multi-omics technologies offers a significant opportunity in the single-cell sequencing (SCS) market. It enables the simultaneous analysis of genomics, transcriptomics, proteomics, and epigenomics at the individual cell level. This comprehensive approach enhances our understanding of cellular functions, disease mechanisms, and patient-specific responses, making it highly valuable for clinical and diagnostic applications. In addition, combining multi-omics with advanced SCS platforms and AI-driven data analysis allows for faster and more accurate insights, which support personalized medicine and biomarker discovery. As adoption continues to grow in hospitals, diagnostic labs, and research institutions, the integration of multi-omics will enhance the impact and reach of single-cell sequencing.

Challenge: Complexities associated with high-dimensional single-cell data

A significant challenge in the single-cell sequencing (SCS) market is managing the complexities of high-dimensional data generated from individual cells. Single-cell datasets often contain millions of measurements per sample, including gene expression levels, protein amounts, and epigenetic modifications, which makes analysis computationally intensive and technically demanding. Additionally, issues such as batch effects, noise, and data sparsity can complicate interpretation and reduce reproducibility. While advanced bioinformatics tools and AI-driven algorithms are helping to address these challenges, the need for specialized expertise and robust computational infrastructure continues to be a barrier, particularly for smaller laboratories and clinical settings.

Single Cell Sequencing Market: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Target identification & validation using scRNA-seq Improved disease understanding via cell subtyping, enabling discovery of novel therapeutic targets
Biomarker discovery & patient stratification in clinical development Improved patient selection for clinical trials and more precise monitoring of drug response and disease progression
High-throughput scRNA-seq using 10x Genomics Chromium & Large-scale scRNA-seq using Parse Biosciences Identification of diverse cell types, understanding cell-to-cell variation, and mapping cellular developmental trajectories
CleanPlex OncoZoom NGS Panels for single-cell circulating tumor cell (CTC) analysis and rare cell profiling Detects somatic mutations across 2,900+ hot spots in 65 oncogenes and tumor suppressor genes | Enables direct single-cell analysis without whole-genome amplification (reduces bias)

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The single-cell sequencing ecosystem involves identifying and analyzing interconnected relationships among various stakeholders, including product and service providers and end users. Product and service providers develop and supply instruments, reagents, consumables, and data analysis tools essential for single-cell workflows. End users, including academic & research institutions, biopharmaceutical companies, clinical laboratories, and CROs, utilize these products and services to conduct high-resolution cellular analysis, drive biomarker discovery, and support precision medicine initiatives.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Single-cell Sequencing Product Market, By Type

Products studied within the single-cell sequencing market include consumables and instruments (pre-sequencing and sequencing), along with supporting software. During the forecast period, consumables are projected to witness the fastest growth owing to their recurring use, high demand in library preparation and sample processing, and increasing adoption of high-throughput and multi-omics workflows.

Single-cell Sequencing Service Market, By Type

Based on type, the single-cell sequencing services market is segmented into pre-sequencing, sequencing, and data analysis & bioinformatic services. In 2024, sequencing services held the largest share of the market as these services provide access to high-cost instruments and expertise, allow scalable processing of large sample volumes, and offer convenient end-to-end solutions that many labs prefer to outsource.

Single-cell Sequencing Product Market, By Workflow

In 2024, products used in the pre-sequencing workflow made up the largest portion of the global single-cell sequencing (SCS) product market. These products are crucial for preparing high-quality samples, which directly affects the accuracy and reliability of the subsequent sequencing processes. Furthermore, the rising adoption of high-throughput and multi-omics workflows has increased the demand for efficient and standardized pre-sequencing products, solidifying this segment's position as the largest contributor to the SCS product market.

Single-cell Sequencing Market, By Sequencing Type

Single-cell RNA sequencing (scRNA-seq) is the most commonly used technique for single-cell sequencing. It allows researchers to profile gene expression at the individual cell level, uncovering cellular diversity that bulk RNA sequencing cannot detect. This method is highly versatile and is applicable in various fields, including cancer research, immunology, developmental biology, and biomarker discovery.

Single-cell Sequencing Market, By Application

Research applications, including translational research and drug discovery, dominate the single-cell sequencing market because SCS enables detailed profiling of individual cells, identification of rare populations, and discovery of biomarkers, accelerating targeted therapy development.

REGION

Asia Pacific to be fastest-growing region in global single-cell sequencing market during forecast period

The Asia Pacific single-cell sequencing market is expected to experience the highest CAGR during the forecast period. This growth is driven by increasing investments in research, a rising prevalence of chronic and complex diseases, and a growing adoption of precision medicine initiatives. Major companies are localizing their operations, forming strategic partnerships, and providing affordable, high-throughput platforms and services that are tailored to meet regional needs. This combination of rising demand and proactive industry strategies is accelerating the adoption of single-cell sequencing and positioning Asia Pacific as a key growth hub in the global market.

Single Cell Sequencing Market: COMPANY EVALUATION MATRIX

In the single-cell sequencing market matrix, 10x Genomics (Star) leads with a commanding market share and a broad product portfolio, enabling widespread adoption across research and clinical applications. Takara Bio and Bio-Rad Laboratories (Emerging Leaders) are gaining traction through targeted product development and growing market presence in single-cell analysis. While 10x Genomics currently dominates in scale and influence, these Emerging Leaders demonstrate significant growth momentum and technological advancements, allowing them to potentially move into the leaders’ quadrant.

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2024 (Value) USD 1.89 Billion
Market Forecast in 2030 (Value) USD 3.46 Billion
Growth Rate CAGR of 12.2% from 2025–2030
Years Considered 2023–2030
Base Year 2024
Forecast Period 2025–2030
Units Considered Value (USD Million), Volume (Units)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, trends, Impact of AI
Segments Covered
  • By Offering:
    • Products
    • Services
  • By Product Type:
    • Consumables
    • Instruments
    • Software
  • By Product Workflow:
    • Pre-sequencing
    • Sequencing
    • Data Analysis & Interpretation
  • By Product End-use Industry:
    • Academic & Research Institutes
    • Pharmaceutical & Biotechnology Companies
    • Hospitals & Clinical Laboratories
    • Contract Research Organizations
  • By Service Type:
    • Pre-sequencing Services
    • Sequencing Services
    • Data Analysis & Bioinformatics Services
  • By Service End User:
    • Academic & Research Institutes
    • Pharmaceutical & Biotechnology Companies
    • Hospitals & Clinical Laboratories
  • By Sequencing Type:
    • scRNA-seq
    • scDNA-seq
    • sc-ATAC-seq
    • Others
  • By Application:
    • Research Applications
    • Diagnostic & Clinical Applications
Regions Covered North America, Asia Pacific, Europe, Latin America, the Middle East, and Africa

WHAT IS IN IT FOR YOU: Single Cell Sequencing Market REPORT CONTENT GUIDE

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
US-based Single-cell Sequencing Technology Provider
  • Detailed competitive landscape with company profiles (platform technology, product portfolio)
  • End-user segmentation by research, clinical diagnostics, and pharmaceutical applications
  • Partnership and ecosystem mapping across academic, biotech, and CRO collaborations
  • Identify technology differentiators and innovation white spaces
  • Detect untapped high-growth customer segments
  • Highlight new partnerships and co-development opportunities for market entry
Clinical Diagnostics Company
  • List of institutions and companies adopting single-cell sequencing technologies across regions
  • Benchmarking adoption rates by application areas like oncology and immunology
  • Analysis of challenges faced by users in workflow integration
  • Understand customer adoption trends and preferences
  • Pinpoint key application areas for targeted marketing
  • Address pain points to improve product-market fit
Leading Contract Research Organizations (CROs)
  • Analysis of service providers offering single-cell sequencing solutions
  • Overview of sequencing capacity and regional availability
  • Customer profiling by industry segment (academia, pharma, diagnostics)
  • Identify key service providers and market niches
  • Assess capacity gaps and expansion potential
  • Target high-value customer segments for service offerings
US-based Single-cell Sequencing Technology Provider
  • Market sizing and segmentation by application areas such as oncology, immunology, neuroscience, and stem cells
  • Growth projections by region and end user
  • Guide product development focus on highest-growth application areas
  • Support investment prioritization and resource allocation
  • Inform go-to-market strategies tailored to region and application

RECENT DEVELOPMENTS

  • July 2025 : CS Genetics launched the 96-sample SingleCell 3’ Gene Expression Kit for high-throughput, same-day single-cell RNA sequencing at a population-scale.
  • May 2025 : BD launched the FACSDiscover A8 Cell Analyzer, a high-performance flow-cytometry system combining spectral analysis and real-time cell imaging. Designed for the pre-sequencing stage of the single-cell sequencing workflow, it enables deep immunophenotyping and precise identification of target cell populations by analyzing over 50 markers simultaneously.
  • March 2025 : Almac Diagnostic Services, part of the Almac Group, introduced a new single-cell RNA sequencing (scRNA-seq) service to strengthen its genomic services portfolio for biopharmaceutical clients.
  • February 2025 : Parse Bioscience launched Evercode WT Penta and Penta 384, enabling single-cell RNA sequencing of up to 5 million cells and 384 samples in a single run.

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
52
2
RESEARCH METHODOLOGY
 
 
 
57
3
EXECUTIVE SUMMARY
 
 
 
72
 
3.1
KEY INSIGHTS AND MARKET HIGHLIGHTS
 
 
 
 
3.2
STRATEGIC IMPERATIVES FOR STAKEHOLDERS
 
 
 
 
3.3
DISRUPTIVE TRENDS SHAPING MARKET
 
 
 
4
PREMIUM INSIGHTS
 
 
 
81
5
MARKET OVERVIEW
AI-driven precision medicine and SBX technology propel single-cell sequencing market's transformative growth.
 
 
 
85
 
5.1
INTRODUCTION
 
 
 
 
5.2
MARKET DYNAMICS
 
 
 
 
 
5.2.1
DRIVERS
 
 
 
 
 
5.2.1.1
Advancements in single-cell sequencing technologies
 
 
 
 
5.2.1.2
Growing focus on precision medicine and biomarker discovery
 
 
 
 
5.2.1.3
Integration of AI & ML in data analysis
 
 
 
 
5.2.1.4
Advantages over conventional bulk sequencing
 
 
 
5.2.2
RESTRAINTS
 
 
 
 
 
5.2.2.1
High cost of single-cell sequencing products & services
 
 
 
5.2.3
OPPORTUNITIES
 
 
 
 
 
5.2.3.1
Emergence of SBX technology
 
 
 
 
5.2.3.2
Integration of multi-omics technologies
 
 
 
 
5.2.3.3
Growth potential of emerging economies
 
 
 
5.2.4
CHALLENGES
 
 
 
 
 
5.2.4.1
Complexities associated with high-dimensional single-cell data
 
 
 
 
5.2.4.2
Biological variability and cell heterogeneity
 
 
5.3
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
 
 
 
 
5.4
VALUE CHAIN ANALYSIS
 
 
 
 
 
5.5
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
5.5.1
EMERGING BUSINESS MODELS AND ECOSYSTEM SHIFT IN SINGLE-CELL SEQUENCING MARKET
 
 
 
5.6
TECHNOLOGY ANALYSIS
 
 
 
 
 
5.6.1
KEY TECHNOLOGIES
 
 
 
 
 
5.6.1.1
Microfluidics partitioning
 
 
 
 
5.6.1.2
NGS
 
 
 
 
5.6.1.3
PCR
 
 
 
 
5.6.1.4
Flow cytometry
 
 
 
5.6.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
5.6.2.1
Magnetic-activated Cell Sorting (MACS)
 
 
 
 
5.6.2.2
Tissue dissociation systems
 
 
 
 
5.6.2.3
Combinatorial indexing
 
 
 
5.6.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
5.6.3.1
Bulk RNA-seq
 
 
 
 
5.6.3.2
In situ hybridization (ISH)
 
 
5.7
PATENT ANALYSIS
 
 
 
 
 
 
5.7.1
PATENT METHODOLOGY
 
 
 
 
5.7.2
PATENTS APPLIED & GRANTED, 2014–2024
 
 
 
5.8
TRADE ANALYSIS
 
 
 
 
 
 
5.8.1
IMPORT DATA (HS CODE 9027)
 
 
 
 
5.8.2
EXPORT DATA (HS CODE 9027)
 
 
 
5.9
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
5.9.1
THREAT OF NEW ENTRANTS
 
 
 
 
5.9.2
THREAT OF SUBSTITUTES
 
 
 
 
5.9.3
BARGAINING POWER OF SUPPLIERS
 
 
 
 
5.9.4
BARGAINING POWER OF BUYERS
 
 
 
 
5.9.5
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
5.10
TARIFF & REGULATORY LANDSCAPE
 
 
 
 
 
5.10.1
TARIFF DATA (HS CODE 9027)
 
 
 
 
5.10.2
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
5.10.3
REGULATORY FRAMEWORK
 
 
 
5.11
PRICING ANALYSIS
 
 
 
 
 
 
5.11.1
AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER, 2022 —2024
 
 
 
 
5.11.2
AVERAGE SELLING PRICE OF PRODUCTS, BY REGION, 2024
 
 
 
5.12
KEY CONFERENCES & EVENTS, 2025–2026
 
 
 
 
5.13
KEY STAKEHOLDERS & BUYING CRITERIA
 
 
 
 
 
 
5.13.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
5.13.2
ROLE OF STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
5.13.3
BUYING CRITERIA
 
 
 
5.14
CUSTOMER LANDSCAPE
 
 
 
 
 
5.14.1
STRATEGIC ANALYSIS OF GROWTH OPPORTUNITIES
 
 
 
 
5.14.2
UNMET NEEDS & WHITE SPACES
 
 
 
5.15
INVESTMENT & FUNDING ACTIVITIES
 
 
 
 
5.16
IMPACT OF AI/GENERATIVE AI ON SINGLE-CELL SEQUENCING MARKET
 
 
 
 
 
 
5.16.1
AI-USE CASES
 
 
 
 
5.16.2
KEY COMPANIES IMPLEMENTING AI
 
 
 
 
5.16.3
FUTURE OF AI IN SINGLE-CELL SEQUENCING
 
 
 
5.17
TRUMP TARIFF IMPACT ON SINGLE-CELL SEQUENCING MARKET
 
 
 
 
 
5.17.1
INTRODUCTION
 
 
 
 
5.17.2
KEY TARIFF RATES
 
 
 
 
5.17.3
PRICE IMPACT ANALYSIS
 
 
 
 
5.17.4
KEY IMPACT ON VARIOUS REGIONS
 
 
 
 
 
5.17.4.1
US
 
 
 
 
5.17.4.2
Europe
 
 
 
 
5.17.4.3
Asia Pacific
 
 
 
 
5.17.4.4
Rest of the World
 
 
 
5.17.5
END-USE INDUSTRY IMPACT
 
 
 
 
 
5.17.5.1
Pharmaceutical & biotech companies
 
 
 
 
5.17.5.2
CROs
 
 
 
 
5.17.5.3
Academic & research institutes
 
 
 
 
5.17.5.4
Hospitals & clinical laboratories
 
6
SINGLE-CELL SEQUENCING MARKET, BY OFFERING
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 15 Data Tables
 
 
 
135
 
6.1
INTRODUCTION
 
 
 
 
6.2
PRODUCTS
 
 
 
 
 
6.2.1
RECURRING DEMAND FOR CONSUMABLES TO DRIVE MARKET
 
 
 
6.3
SERVICES
 
 
 
 
 
6.3.1
HIGH RELIANCE ON SERVICE PROVIDERS FOR SEQUENCING ACTIVITIES TO PROPEL MARKET
 
 
7
SINGLE-CELL SEQUENCING PRODUCT MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million and Units | 90 Data Tables
 
 
 
144
 
7.1
INTRODUCTION
 
 
 
 
7.2
CONSUMABLES
 
 
 
 
 
7.2.1
PRE-SEQUENCING REAGENTS & KITS
 
 
 
 
 
7.2.1.1
Ongoing product launches & upgrades to fuel uptake
 
 
 
7.2.2
SEQUENCING REAGENTS & KITS
 
 
 
 
 
7.2.2.1
Ability to provide high-throughput and high-fidelity nucleotide reading to boost demand
 
 
7.3
INSTRUMENTS
 
 
 
 
 
7.3.1
PRE-SEQUENCING INSTRUMENTS
 
 
 
 
 
7.3.1.1
Microfluidic instruments
 
 
 
 
7.3.1.2
Cell sorters
 
 
 
 
7.3.1.3
PCR instruments
 
 
 
 
7.3.1.4
LCM instruments
 
 
 
 
7.3.1.5
Other pre-sequencing instruments
 
 
 
7.3.2
SEQUENCING PLATFORMS
 
 
 
 
 
7.3.2.1
Rising adoption across research applications to drive market
 
 
7.4
SOFTWARE
 
 
 
 
 
7.4.1
SOFTWARE TOOLS
 
 
 
 
 
7.4.1.1
Rising demand for accurate & scalable processing of sequencing data to support market growth
 
 
 
7.4.2
DATA STORAGE & MANAGEMENT SOFTWARE
 
 
 
 
 
7.4.2.1
Secure handling, archival, and retrieval of large volumes of data to support market growth
 
8
SINGLE-CELL SEQUENCING PRODUCT MARKET, BY WORKFLOW
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 22 Data Tables
 
 
 
187
 
8.1
INTRODUCTION
 
 
 
 
8.2
PRE-SEQUENCING WORKFLOW
 
 
 
 
 
8.2.1
ABILITY TO ENABLE HIGH-THROUGHPUT WORKFLOW IN CLINICAL & RESEARCH SETTINGS TO DRIVE MARKET
 
 
 
8.3
SEQUENCING WORKFLOW
 
 
 
 
 
8.3.1
DEMAND FOR MULTI-OMIC SEQUENCING PLATFORMS IN TRANSLATIONAL RESEARCH & ONCOLOGY TO PROPEL MARKET
 
 
 
8.4
DATA ANALYSIS & INTERPRETATION WORKFLOW
 
 
 
 
 
8.4.1
COMPLEXITY OF SINGLE-CELL DATASETS TO FUEL MARKET
 
 
9
SINGLE-CELL SEQUENCING PRODUCT MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 29 Data Tables
 
 
 
199
 
9.1
INTRODUCTION
 
 
 
 
9.2
ACADEMIC & RESEARCH INSTITUTES
 
 
 
 
 
9.2.1
RISING FOCUS ON LIFE SCIENCES RESEARCH SUPPORTED BY FAVORABLE GRANTS & FUNDS TO DRIVE MARKET
 
 
 
9.3
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
 
 
 
 
 
9.3.1
INCREASING DEMAND FOR DRUG DISCOVERY & DEVELOPMENT TO PROPEL MARKET
 
 
 
9.4
HOSPITALS & CLINICAL LABORATORIES
 
 
 
 
 
9.4.1
RISING INTEGRATION OF ADVANCED SEQUENCING TECHNOLOGIES INTO CLINICAL WORKFLOWS TO BOOST DEMAND
 
 
 
9.5
CONTRACT RESEARCH ORGANIZATIONS (CROS)
 
 
 
 
 
9.5.1
INCREASING RELIANCE ON OUTSOURCING R&D ACTIVITIES TO SUPPORT MARKET GROWTH
 
 
10
SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 37 Data Tables
 
 
 
215
 
10.1
INTRODUCTION
 
 
 
 
10.2
PRE-SEQUENCING SERVICES
 
 
 
 
 
10.2.1
SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES
 
 
 
 
 
10.2.1.1
Rising demand for high-resolution cell profiling services to fuel market
 
 
 
10.2.2
LIBRARY PREPARATION SERVICES
 
 
 
 
 
10.2.2.1
Adoption of single-cell applications to fuel market
 
 
10.3
SEQUENCING SERVICES
 
 
 
 
 
10.3.1
INCREASING DEMAND FOR SCALABLE & APPLICATION-SPECIFIC SEQUENCING OUTPUTS TO DRIVE MARKET
 
 
 
10.4
DATA ANALYSIS & BIOINFORMATICS SERVICES
 
 
 
 
 
10.4.1
INCREASING FOCUS ON CREATION OF END-TO-END ANALYSIS PIPELINES TO SUPPORT MARKET GROWTH
 
 
11
SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 22 Data Tables
 
 
 
235
 
11.1
INTRODUCTION
 
 
 
 
11.2
ACADEMIC & RESEARCH INSTITUTES
 
 
 
 
 
11.2.1
EXECUTION OF COMPLEX & LARGE-SCALE CELLULAR STUDIES TO DRIVE MARKET
 
 
 
11.3
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
 
 
 
 
 
11.3.1
INTEGRATION OF HIGH-THROUGHPUT SINGLE-CELL PLATFORMS IN DRUG DISCOVERY ACTIVITIES TO PROPEL MARKET
 
 
 
11.4
HOSPITALS & CLINICAL LABORATORIES
 
 
 
 
 
11.4.1
INCREASING USE ACROSS ONCOLOGY DIAGNOSTICS TO SUPPORT MARKET GROWTH
 
 
12
SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 29 Data Tables
 
 
 
247
 
12.1
INTRODUCTION
 
 
 
 
12.2
SINGLE-CELL TRANSCRIPTOME SEQUENCING (SCRNA-SEQ)
 
 
 
 
 
12.2.1
WIDE APPLICATIONS FOR GENE EXPRESSION STUDIES TO DRIVE MARKET
 
 
 
12.3
SINGLE-CELL GENOME SEQUENCING (SCDNA-SEQ)
 
 
 
 
 
12.3.1
ANALYSIS OF GENOMIC VARIATIONS WITH COMPLEX ADVANCEMENTS TO FUEL MARKET
 
 
 
12.4
SINGLE-CELL ATAC SEQUENCING (SCATAC-SEQ)
 
 
 
 
 
12.4.1
IDENTIFICATION OF OPEN DNA REGIONS TO SUPPORT MARKET GROWTH
 
 
 
12.5
OTHER SINGLE-CELL SEQUENCING TYPES
 
 
 
13
SINGLE-CELL SEQUENCING MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 52 Data Tables
 
 
 
263
 
13.1
INTRODUCTION
 
 
 
 
13.2
RESEARCH APPLICATIONS
 
 
 
 
 
13.2.1
BASIC & TRANSLATION RESEARCH
 
 
 
 
 
13.2.1.1
Cancer research
 
 
 
 
13.2.1.2
Stem cell & developmental biology
 
 
 
 
13.2.1.3
Neurology & brain research
 
 
 
 
13.2.1.4
Microbiology & infectious diseases
 
 
 
 
13.2.1.5
Organ development & regenerative medicine
 
 
 
13.2.2
DRUG DISCOVERY & DEVELOPMENT
 
 
 
 
 
13.2.2.1
Improved target validation and patient stratification using single-cell data to drive market
 
 
13.3
DIAGNOSTIC & CLINICAL APPLICATIONS
 
 
 
 
 
13.3.1
RISING UPTAKE IN MOLECULAR DIAGNOSTICS & PERSONALIZED MEDICINE TO SUPPORT MARKET GROWTH
 
 
14
SINGLE-CELL SEQUENCING MARKET, BY REGION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 433 Data Tables
 
 
 
291
 
14.1
INTRODUCTION
 
 
 
 
14.2
NORTH AMERICA
 
 
 
 
 
14.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
 
 
 
 
14.2.2
US
 
 
 
 
 
14.2.2.1
Increasing R&D investments & funding to drive market
 
 
 
14.2.3
CANADA
 
 
 
 
 
14.2.3.1
High prevalence of hemophilia to propel market
 
 
14.3
EUROPE
 
 
 
 
 
14.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
 
 
 
 
14.3.2
GERMANY
 
 
 
 
 
14.3.2.1
Increasing awareness of advanced cell therapies to drive market
 
 
 
14.3.3
UK
 
 
 
 
 
14.3.3.1
Rising adoption of single-cell analysis products to boost demand
 
 
 
14.3.4
FRANCE
 
 
 
 
 
14.3.4.1
Favorable government funding investments for genomics to fuel market
 
 
 
14.3.5
ITALY
 
 
 
 
 
14.3.5.1
Growing focus on cell biology research to fuel uptake
 
 
 
14.3.6
SPAIN
 
 
 
 
 
14.3.6.1
Increasing number of biotechnology companies to drive market
 
 
 
14.3.7
REST OF EUROPE
 
 
 
14.4
ASIA PACIFIC
 
 
 
 
 
14.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
 
 
 
 
14.4.2
CHINA
 
 
 
 
 
14.4.2.1
Increasing incidence of infectious diseases to drive market
 
 
 
14.4.3
JAPAN
 
 
 
 
 
14.4.3.1
Growing demand for personalized medicine to drive market
 
 
 
14.4.4
INDIA
 
 
 
 
 
14.4.4.1
Expansion of activities in cell biology and biotech sectors to drive market
 
 
 
14.4.5
SOUTH KOREA
 
 
 
 
 
14.4.5.1
Increasing number of strategic alliances to boost market
 
 
 
14.4.6
AUSTRALIA
 
 
 
 
 
14.4.6.1
Rising establishment of life science companies to boost demand
 
 
 
14.4.7
REST OF ASIA PACIFIC
 
 
 
14.5
LATIN AMERICA
 
 
 
 
 
14.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
 
 
 
 
14.5.2
BRAZIL
 
 
 
 
 
14.5.2.1
Focus on advancements in manufacturing infrastructure for biopharmaceuticals to propel market
 
 
 
14.5.3
MEXICO
 
 
 
 
 
14.5.3.1
Favorable government support for advanced sequencing technologies to drive market
 
 
 
14.5.4
REST OF LATIN AMERICA
 
 
 
14.6
MIDDLE EAST
 
 
 
 
 
14.6.1
MACROECONOMIC OUTLOOK IN MIDDLE EAST
 
 
 
 
14.6.2
GCC COUNTRIES
 
 
 
 
 
14.6.2.1
Kingdom of Saudi Arabia (KSA)
 
 
 
 
14.6.2.2
United Arab Emirates
 
 
 
 
14.6.2.3
Other GCC Countries
 
 
 
14.6.3
REST OF MIDDLE EAST
 
 
 
14.7
AFRICA
 
 
 
 
 
14.7.1
RISING FOCUS ON DRUG DISCOVERY & DEVELOPMENT TO SUPPORT MARKET GROWTH
 
 
 
 
14.7.2
MACROECONOMIC OUTLOOK FOR AFRICA
 
 
15
COMPETITIVE LANDSCAPE
Uncover strategic insights and market dynamics shaping key players' dominance and emerging leaders' rise.
 
 
 
493
 
15.1
OVERVIEW
 
 
 
 
15.2
KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021–2025
 
 
 
 
15.3
REVENUE ANALYSIS, 2022–2024
 
 
 
 
 
15.4
MARKET SHARE ANALYSIS, 2024
 
 
 
 
 
15.5
COMPANY EVALUATION MATRIX: KEY PRODUCT PROVIDERS, 2024
 
 
 
 
 
 
15.5.1
STARS
 
 
 
 
15.5.2
EMERGING LEADERS
 
 
 
 
15.5.3
PERVASIVE PLAYERS
 
 
 
 
15.5.4
PARTICIPANTS
 
 
 
 
15.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
 
 
 
 
 
15.5.5.1
Company footprint
 
 
 
 
15.5.5.2
Region footprint
 
 
 
 
15.5.5.3
Product type footprint
 
 
 
 
15.5.5.4
Workflow footprint
 
 
 
 
15.5.5.5
Application footprint
 
 
15.6
COMPANY EVALUATION MATRIX: KEY SERVICE PROVIDERS, 2024
 
 
 
 
 
 
15.6.1
STARS
 
 
 
 
15.6.2
EMERGING LEADERS
 
 
 
 
15.6.3
PERVASIVE PLAYERS
 
 
 
 
15.6.4
PARTICIPANTS
 
 
 
 
15.6.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
 
 
 
 
 
15.6.5.1
Company footprint
 
 
 
 
15.6.5.2
Region footprint
 
 
 
 
15.6.5.3
Service footprint
 
 
 
 
15.6.5.4
Application footprint
 
 
15.7
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
 
 
 
 
 
 
15.7.1
PROGRESSIVE COMPANIES
 
 
 
 
15.7.2
RESPONSIVE COMPANIES
 
 
 
 
15.7.3
DYNAMIC COMPANIES
 
 
 
 
15.7.4
STARTING BLOCKS
 
 
 
 
15.7.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
 
 
 
 
 
15.7.5.1
Detailed list of key startups/SMEs
 
 
 
 
15.7.5.2
Competitive benchmarking of key startups/SMEs
 
 
15.8
COMPANY VALUATION & FINANCIAL METRICS
 
 
 
 
 
15.8.1
FINANCIAL METRICS
 
 
 
 
15.8.2
COMPANY VALUATION
 
 
 
15.9
BRAND/PRODUCT COMPARISON
 
 
 
 
 
 
15.9.1
BRAND/PRODUCT COMPARATIVE ANALYSIS
 
 
 
15.10
COMPETITIVE SCENARIO
 
 
 
 
 
15.10.1
PRODUCT & SERVICE LAUNCHES
 
 
 
 
15.10.2
DEALS
 
 
16
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
524
 
16.1
INTRODUCTION
 
 
 
 
16.2
KEY PRODUCT PROVIDERS
 
 
 
 
 
16.2.1
BECTON, DICKINSON AND COMPANY (BD)
 
 
 
 
 
16.2.1.1
Business overview
 
 
 
 
16.2.1.2
Products offered
 
 
 
 
16.2.1.3
Recent developments
 
 
 
 
16.2.1.4
MnM view
 
 
 
16.2.2
THERMO FISHER SCIENTIFIC INC.
 
 
 
 
16.2.3
DANAHER CORPORATION
 
 
 
 
16.2.4
10X GENOMICS
 
 
 
 
16.2.5
ILLUMINA, INC.
 
 
 
 
16.2.6
MERCK KGAA
 
 
 
 
16.2.7
QIAGEN N.V.
 
 
 
 
16.2.8
BIO-RAD LABORATORIES, INC.
 
 
 
 
16.2.9
TECAN TRADING AG
 
 
 
 
16.2.10
CYTEK BIOSCIENCES
 
 
 
 
16.2.11
TAKARA BIO INC.
 
 
 
 
16.2.12
BIO-TECHNE
 
 
 
 
16.2.13
PACBIO
 
 
 
16.3
KEY SERVICE PROVIDERS
 
 
 
 
 
16.3.1
AZENTA US INC.
 
 
 
 
16.3.2
NOVOGENE CO., LTD.
 
 
 
 
16.3.3
IQVIA INC.
 
 
 
 
16.3.4
ALMAC GROUP
 
 
 
 
16.3.5
CEGAT GMBH
 
 
 
 
16.3.6
ACTIVE MOTIF
 
 
 
16.4
OTHER PRODUCT PROVIDERS
 
 
 
 
 
16.4.1
SINGLERON BIOTECHNOLOGIES
 
 
 
 
16.4.2
CELL MICROSYSTEMS
 
 
 
 
16.4.3
NANOCELLECT BIOMEDICAL
 
 
 
 
16.4.4
OXFORD NANOPORE TECHNOLOGIES PLC.
 
 
 
 
16.4.5
REVVITY
 
 
 
 
16.4.6
PARSE BIOSCIENCES
 
 
 
 
16.4.7
ULTIMA GENOMICS
 
 
 
 
16.4.8
MISSION BIO
 
 
 
16.5
OTHER SERVICE PROVIDERS
 
 
 
 
 
16.5.1
SINGLE CELL DISCOVERIES BV
 
 
 
 
16.5.2
ADMERA HEALTH
 
 
 
 
16.5.3
BGI
 
 
 
 
16.5.4
SIGNIOSBIO
 
 
 
 
16.5.5
MACROGEN CO., LTD.
 
 
 
 
16.5.6
LEXOGEN GMBH
 
 
 
 
16.5.7
DISCOVERY LIFE SCIENCES
 
 
 
 
16.5.8
CELLCARTA
 
 
 
 
16.5.9
SINGULOMICS CORPORATION
 
 
 
 
16.5.10
SEQMATIC LLC.
 
 
17
APPENDIX
 
 
 
611
 
17.1
DISCUSSION GUIDE
 
 
 
 
17.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
17.3
CUSTOMIZATION OPTIONS
 
 
 
 
17.4
RELATED REPORTS
 
 
 
 
17.5
AUTHOR DETAILS
 
 
 
LIST OF TABLES
 
 
 
 
 
TABLE 1
SINGLE-CELL SEQUENCING MARKET: INCLUSIONS & EXCLUSIONS
 
 
 
 
TABLE 2
IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
 
 
 
 
TABLE 3
SINGLE-CELL SEQUENCING MARKET: RISK ASSESSMENT ANALYSIS
 
 
 
 
TABLE 4
SINGLE-CELL SEQUENCING MARKET: IMPACT ANALYSIS
 
 
 
 
TABLE 5
SINGLE-CELL SEQUENCING MARKET: RAW MATERIAL VENDORS
 
 
 
 
TABLE 6
SINGLE-CELL SEQUENCING MARKET: EMERGING BUSINESS MODELS & STRATEGIC ADVANTAGE
 
 
 
 
TABLE 7
PATENTS APPLIED & GRANTED, 2014–2024
 
 
 
 
TABLE 8
INNOVATIONS & PATENT REGISTRATIONS, 2024
 
 
 
 
TABLE 9
IMPORT VALUE OF HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020–2024 (USD THOUSANDS)
 
 
 
 
TABLE 10
IMPORT VOLUME FOR HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020–2024 (TONS)
 
 
 
 
TABLE 11
EXPORT VALUE OF HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020–2024 (USD THOUSANDS)
 
 
 
 
TABLE 12
EXPORT VOLUME FOR HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020–2024 (TONS)
 
 
 
 
TABLE 13
SINGLE-CELL SEQUENCING MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
TABLE 14
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 15
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 16
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 17
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 18
SINGLE-CELL SEQUENCING MARKET: REGULATORY GUIDELINES
 
 
 
 
TABLE 19
AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER, 2022–2024
 
 
 
 
TABLE 20
AVERAGE SELLING PRICE OF PRODUCTS, BY REGION, 2024
 
 
 
 
TABLE 21
SINGLE-CELL SEQUENCING MARKET: KEY CONFERENCES & EVENTS, 2025–2026
 
 
 
 
TABLE 22
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR SINGLE-CELL SEQUENCING PRODUCTS
 
 
 
 
TABLE 23
BUYING CRITERIA FOR SINGLE-CELL SEQUENCING PRODUCTS, BY END USER
 
 
 
 
TABLE 24
SINGLE-CELL SEQUENCING MARKET: STRATEGIC ANALYSIS OF GROWTH OPPORTUNITIES
 
 
 
 
TABLE 25
KEY COMPANIES IMPLEMENTING AI IN SINGLE-CELL SEQUENCING MARKET
 
 
 
 
TABLE 26
KEY PRODUCT-RELATED TARIFF: MISCELLANEOUS CHEMICAL PRODUCTS, ELECTRICAL MACHINERY & EQUIPMENT, AND PARTS THEREOF.
 
 
 
 
TABLE 27
SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 28
SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 29
NORTH AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 30
EUROPE: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 31
ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 32
LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 33
MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 34
GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 35
SINGLE-CELL SEQUENCING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 36
NORTH AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 37
EUROPE: SINGLE-CELL SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 38
ASIA PACIFIC: SINGLE-CELL SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 39
LATIN AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 40
MIDDLE EAST: SINGLE-CELL SEQUENCING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 41
GCC COUNTRIES: SINGLE-CELL SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 42
SINGLE-CELL SEQUENCING PRODUCT MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 43
SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 44
PRE-SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 45
NORTH AMERICA: PRE-SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 46
EUROPE: PRE-SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 47
ASIA PACIFIC: PRE-SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 48
LATIN AMERICA: PRE-SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 49
MIDDLE EAST: PRE-SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 50
GCC COUNTRIES: PRE-SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 51
SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 52
NORTH AMERICA: SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 53
EUROPE: SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 54
ASIA PACIFIC: SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 55
LATIN AMERICA: SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 56
MIDDLE EAST: SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 57
GCC COUNTRIES: SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 58
SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 59
PRE-SEQUENCING INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 60
NORTH AMERICA: PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 61
EUROPE: PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 62
ASIA PACIFIC: PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 63
LATIN AMERICA: PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 64
MIDDLE EAST: PRE-SEQUENCING INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 65
GCC COUNTRIES: PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 66
PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 67
MICROFLUIDIC INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 68
NORTH AMERICA: MICROFLUIDIC INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 69
EUROPE: MICROFLUIDIC INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 70
ASIA PACIFIC: MICROFLUIDIC INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 71
LATIN AMERICA: MICROFLUIDIC INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 72
MIDDLE EAST: MICROFLUIDIC INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 73
GCC COUNTRIES: MICROFLUIDIC INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 74
CELL SORTERS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 75
NORTH AMERICA: CELL SORTERS MARKET, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 76
EUROPE: CELL SORTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 77
ASIA PACIFIC: CELL SORTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 78
LATIN AMERICA: CELL SORTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 79
MIDDLE EAST: CELL SORTERS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 80
GCC COUNTRIES: CELL SORTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 81
PCR INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 82
NORTH AMERICA: PCR INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 83
EUROPE: PCR INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 84
ASIA PACIFIC: PCR INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 85
LATIN AMERICA: PCR INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 86
MIDDLE EAST: PCR INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 87
GCC COUNTRIES: PCR INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 88
LCM INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 89
NORTH AMERICA: LCM INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 90
EUROPE: LCM INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 91
ASIA PACIFIC: LCM INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 92
LATIN AMERICA: LCM INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 93
MIDDLE EAST: LCM INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 94
GCC COUNTRIES: LCM INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 95
OTHER PRE-SEQUENCING INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 96
NORTH AMERICA: OTHER PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 97
EUROPE: OTHER PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 98
ASIA PACIFIC: OTHER PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 99
LATIN AMERICA: OTHER PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 100
MIDDLE EAST: OTHER PRE-SEQUENCING INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 101
GCC COUNTRIES: OTHER PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 102
SEQUENCING PLATFORMS MARKET, BY TYPE, 2023–2030 (UNITS)
 
 
 
 
TABLE 103
SEQUENCING PLATFORMS INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 104
NORTH AMERICA: SEQUENCING PLATFORMS INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 105
EUROPE: SEQUENCING PLATFORMS INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 106
ASIA PACIFIC: SEQUENCING PLATFORMS INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 107
LATIN AMERICA: SEQUENCING PLATFORMS INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 108
MIDDLE EAST: SEQUENCING PLATFORMS INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 109
GCC COUNTRIES: SEQUENCING PLATFORMS INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 110
SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 111
NORTH AMERICA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 112
EUROPE: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 113
ASIA PACIFIC: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 114
LATIN AMERICA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 115
MIDDLE EAST: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 116
GCC COUNTRIES: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 117
SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 118
SINGLE-CELL SEQUENCING SOFTWARE TOOLS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 119
NORTH AMERICA: SINGLE-CELL SEQUENCING SOFTWARE TOOLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 120
EUROPE: SINGLE-CELL SEQUENCING SOFTWARE TOOLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 121
ASIA PACIFIC: SINGLE-CELL SEQUENCING SOFTWARE TOOLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 122
LATIN AMERICA: SINGLE-CELL SEQUENCING SOFTWARE TOOLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 123
MIDDLE EAST: SINGLE-CELL SEQUENCING SOFTWARE TOOLS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 124
GCC COUNTRIES: SINGLE-CELL SEQUENCING SOFTWARE TOOLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 125
SINGLE-CELL SEQUENCING DATA STORAGE & MANAGEMENT SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 126
NORTH AMERICA: SINGLE-CELL SEQUENCING DATA STORAGE & MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 127
EUROPE: SINGLE-CELL SEQUENCING DATA STORAGE & MANAGEMENT SOFTWARE MARKET, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 128
ASIA PACIFIC: SINGLE-CELL SEQUENCING DATA STORAGE & MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 129
LATIN AMERICA: SINGLE-CELL SEQUENCING DATA STORAGE & MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 130
MIDDLE EAST: SINGLE-CELL SEQUENCING DATA STORAGE & MANAGEMENT SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 131
GCC COUNTRIES: SINGLE-CELL SEQUENCING DATA STORAGE & MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 132
SINGLE-CELL SEQUENCING PRODUCT MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 133
PRE-SEQUENCING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 134
NORTH AMERICA: PRE-SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 135
EUROPE: PRE-SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 136
ASIA PACIFIC: PRE-SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 137
LATIN AMERICA: PRE-SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 138
MIDDLE EAST: PRE-SEQUENCING PRODUCT MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 139
GCC COUNTRIES: PRE-SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 140
SEQUENCING PRODUCT MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 141
NORTH AMERICA: SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 142
EUROPE: SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 143
ASIA PACIFIC: SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 144
LATIN AMERICA: SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 145
MIDDLE EAST: SEQUENCING PRODUCT MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 146
GCC COUNTRIES: SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 147
DATA ANALYSIS & INTERPRETATION PRODUCT MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 148
NORTH AMERICA: DATA ANALYSIS & INTERPRETATION PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 149
EUROPE: DATA ANALYSIS & INTERPRETATION PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 150
ASIA PACIFIC: DATA ANALYSIS & INTERPRETATION PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 151
LATIN AMERICA: DATA ANALYSIS & INTERPRETATION PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 152
MIDDLE EAST: DATA ANALYSIS & INTERPRETATION PRODUCT MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 153
GCC COUNTRIES: DATA ANALYSIS & INTERPRETATION PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 154
SINGLE-CELL SEQUENCING PRODUCT MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 155
SINGLE-CELL SEQUENCING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 156
NORTH AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 157
EUROPE: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 158
ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 159
LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 160
MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 161
GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 162
SINGLE-CELL SEQUENCING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 163
NORTH AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 164
EUROPE: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 165
ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 166
LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 167
MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 168
GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 169
SINGLE-CELL SEQUENCING PRODUCT MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 170
NORTH AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 171
EUROPE: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 172
ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 173
LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 174
MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 175
GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 176
SINGLE-CELL SEQUENCING PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 177
NORTH AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 178
EUROPE: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 179
ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 180
LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 181
MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 182
GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 183
SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 184
PRE-SEQUENCING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 185
NORTH AMERICA: PRE-SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 186
EUROPE: PRE-SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 187
ASIA PACIFIC: PRE-SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 188
LATIN AMERICA: PRE-SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 189
MIDDLE EAST: PRE-SEQUENCING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 190
GCC COUNTRIES: PRE-SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 191
PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 192
SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 193
NORTH AMERICA: SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 194
EUROPE: SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 195
ASIA PACIFIC: SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 196
LATIN AMERICA: SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 197
MIDDLE EAST: SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 198
GCC COUNTRIES: SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 199
LIBRARY PREPARATION SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 200
NORTH AMERICA: LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 201
EUROPE: LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 202
ASIA PACIFIC: LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 203
LATIN AMERICA: LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 204
MIDDLE EAST: LIBRARY PREPARATION SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 205
GCC COUNTRIES: LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 206
SEQUENCING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 207
NORTH AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 208
EUROPE: SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 209
ASIA PACIFIC: SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 210
LATIN AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 211
MIDDLE EAST: SEQUENCING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 212
GCC COUNTRIES: SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 213
DATA ANALYSIS & BIOINFORMATICS SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 214
NORTH AMERICA: DATA ANALYSIS & BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 215
EUROPE: DATA ANALYSIS & BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 216
ASIA PACIFIC: DATA ANALYSIS & BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 217
LATIN AMERICA: DATA ANALYSIS & BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 218
MIDDLE EAST: DATA ANALYSIS & BIOINFORMATICS SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 219
GCC COUNTRIES: DATA ANALYSIS & BIOINFORMATICS SERVICES MARKET,BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 220
SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 221
SINGLE-CELL SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 222
NORTH AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 223
EUROPE: SINGLE-CELL SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 224
ASIA PACIFIC: SINGLE-CELL SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 225
LATIN AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 226
MIDDLE EAST: SINGLE-CELL SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 227
GCC COUNTRIES: SINGLE-CELL SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 228
SINGLE-CELL SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 229
NORTH AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 230
EUROPE: SINGLE-CELL SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 231
ASIA PACIFIC: SINGLE-CELL SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 232
LATIN AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 233
MIDDLE EAST: SINGLE-CELL SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 234
GCC COUNTRIES: SINGLE-CELL SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 235
SINGLE-CELL SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 236
NORTH AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 237
EUROPE: SINGLE-CELL SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 238
ASIA PACIFIC: SINGLE-CELL SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 239
LATIN AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 240
MIDDLE EAST: SINGLE-CELL SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 241
GCC COUNTRIES: SINGLE-CELL SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 242
SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 243
SINGLE-CELL TRANSCRIPTOME SEQUENCING MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 244
NORTH AMERICA: SINGLE-CELL TRANSCRIPTOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 245
EUROPE: SINGLE-CELL TRANSCRIPTOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 246
ASIA PACIFIC: SINGLE-CELL TRANSCRIPTOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 247
LATIN AMERICA: SINGLE-CELL TRANSCRIPTOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 248
MIDDLE EAST: SINGLE-CELL TRANSCRIPTOME SEQUENCING MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 249
GCC COUNTRIES: SINGLE-CELL TRANSCRIPTOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 250
SINGLE-CELL GENOME SEQUENCING MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 251
NORTH AMERICA: SINGLE-CELL GENOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 252
EUROPE: SINGLE-CELL GENOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 253
ASIA PACIFIC: SINGLE-CELL GENOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 254
LATIN AMERICA: SINGLE-CELL GENOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 255
MIDDLE EAST: SINGLE-CELL GENOME SEQUENCING MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 256
GCC COUNTRIES: SINGLE-CELL GENOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 257
SINGLE-CELL ATAC SEQUENCING MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 258
NORTH AMERICA: SINGLE-CELL ATAC SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 259
EUROPE: SINGLE-CELL ATAC SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 260
ASIA PACIFIC: SINGLE-CELL ATAC SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 261
LATIN AMERICA: SINGLE-CELL ATAC SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 262
MIDDLE EAST: SINGLE-CELL ATAC SEQUENCING MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 263
GCC COUNTRIES: SINGLE-CELL ATAC SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 264
OTHER SINGLE-CELL SEQUENCING TYPES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 265
NORTH AMERICA: OTHER SINGLE-CELL SEQUENCING TYPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 266
EUROPE: OTHER SINGLE-CELL SEQUENCING TYPES MARKET, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 267
ASIA PACIFIC: OTHER SINGLE-CELL SEQUENCING TYPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 268
LATIN AMERICA: OTHER SINGLE-CELL SEQUENCING TYPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 269
MIDDLE EAST: OTHER SINGLE-CELL SEQUENCING TYPES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 270
GCC COUNTRIES: OTHER SINGLE-CELL SEQUENCING TYPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 271
SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 272
SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 273
SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATIONAL RESEARCH, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 274
SINGLE-CELL SEQUENCING MARKET FOR CANCER RESEARCH, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 275
NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 276
EUROPE: SINGLE-CELL SEQUENCING MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 277
ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 278
LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 279
MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR CANCER RESEARCH, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 280
GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 281
SINGLE-CELL SEQUENCING MARKET FOR STEM CELL & DEVELOPMENTAL BIOLOGY, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 282
NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR STEM CELL & DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 283
EUROPE: SINGLE-CELL SEQUENCING MARKET FOR STEM CELL & DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 284
ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR STEM CELL & DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 285
LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR STEM CELL & DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 286
MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR STEM CELL & DEVELOPMENTAL BIOLOGY, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 287
GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR STEM CELL & DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 288
SINGLE-CELL SEQUENCING MARKET FOR NEUROLOGY & BRAIN RESEARCH, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 289
NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR NEUROLOGY & BRAIN RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 290
EUROPE: SINGLE-CELL SEQUENCING MARKET FOR NEUROLOGY & BRAIN RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 291
ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR NEUROLOGY & BRAIN RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 292
LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR NEUROLOGY & BRAIN RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 293
MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR NEUROLOGY & BRAIN RESEARCH, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 294
GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR NEUROLOGY & BRAIN RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 295
SINGLE-CELL SEQUENCING MARKET FOR MICROBIOLOGY & INFECTIOUS DISEASES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 296
NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR MICROBIOLOGY & INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 297
EUROPE: SINGLE-CELL SEQUENCING MARKET FOR MICROBIOLOGY & INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 298
ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR MICROBIOLOGY & INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 299
LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR MICROBIOLOGY & INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 300
MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR MICROBIOLOGY & INFECTIOUS DISEASES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 301
GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR MICROBIOLOGY & INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 302
SINGLE-CELL SEQUENCING MARKET FOR ORGAN DEVELOPMENT & REGENERATIVE MEDICINE, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 303
NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR ORGAN DEVELOPMENT & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 304
EUROPE: SINGLE-CELL SEQUENCING MARKET FOR ORGAN DEVELOPMENT & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 305
ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR ORGAN DEVELOPMENT & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 306
LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR ORGAN DEVELOPMENT & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 307
MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR ORGAN DEVELOPMENT & REGENERATIVE MEDICINE, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 308
GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR ORGAN DEVELOPMENT & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 309
SINGLE-CELL SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 310
NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 311
EUROPE: SINGLE-CELL SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 312
ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 313
LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 314
MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 315
GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 316
SINGLE-CELL SEQUENCING MARKET FOR DIAGNOSTIC & CLINICAL APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 317
NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR DIAGNOSTIC & CLINICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 318
EUROPE: SINGLE-CELL SEQUENCING MARKET FOR DIAGNOSTIC & CLINICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 319
ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR DIAGNOSTIC & CLINICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 320
LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR DIAGNOSTIC & CLINICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 321
MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR DIAGNOSTIC & CLINICAL APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 322
GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR DIAGNOSTIC & CLINICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 323
SINGLE-CELL SEQUENCING MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 324
NORTH AMERICA: MACROECONOMIC INDICATORS
 
 
 
 
TABLE 325
NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 326
NORTH AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 327
NORTH AMERICA: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 328
NORTH AMERICA: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 329
NORTH AMERICA: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 330
NORTH AMERICA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 331
NORTH AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 332
NORTH AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 333
NORTH AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 334
NORTH AMERICA: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 335
NORTH AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 336
NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 337
NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 338
NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 339
NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 340
NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 341
US: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 342
US: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 343
US: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 344
US: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 345
US: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 346
US: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 347
US: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 348
US: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 349
US: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 350
US: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 351
US: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 352
US: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 353
US: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 354
US: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 355
US: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 356
CANADA: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 357
CANADA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 358
CANADA: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 359
CANADA: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 360
CANADA: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 361
CANADA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 362
CANADA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 363
CANADA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 364
CANADA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 365
CANADA: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 366
CANADA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 367
CANADA: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 368
CANADA: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 369
CANADA: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 370
CANADA: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 371
EUROPE: MACROECONOMIC INDICATORS
 
 
 
 
TABLE 372
EUROPE: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 373
EUROPE: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 374
EUROPE: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 375
EUROPE: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 376
EUROPE: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 377
EUROPE: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 378
EUROPE: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 379
EUROPE: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 380
EUROPE: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 381
EUROPE: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 382
EUROPE: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 383
EUROPE: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 384
EUROPE: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 385
EUROPE: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 386
EUROPE: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 387
EUROPE: SINGLE-CELL SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 388
GERMANY: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 389
GERMANY: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 390
GERMANY: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 391
GERMANY: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 392
GERMANY: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 393
GERMANY: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 394
GERMANY: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 395
GERMANY: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 396
GERMANY: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 397
GERMANY: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 398
GERMANY: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 399
GERMANY: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 400
GERMANY: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 401
GERMANY: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 402
GERMANY: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 403
UK: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 404
UK: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 405
UK: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 406
UK: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 407
UK: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 408
UK: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE,2023–2030 (USD MILLION)
 
 
 
 
TABLE 409
UK: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW,2023–2030 (USD MILLION)
 
 
 
 
TABLE 410
UK: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 411
UK: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 412
UK: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 413
UK: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 414
UK: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 415
UK: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 416
UK: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 417
UK: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 418
FRANCE: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 419
FRANCE: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 420
FRANCE: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 421
FRANCE: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 422
FRANCE: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 423
FRANCE: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 424
FRANCE: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 425
FRANCE: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 426
FRANCE: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 427
FRANCE: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 428
FRANCE: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 429
FRANCE: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 430
FRANCE: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 431
FRANCE: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 432
FRANCE: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 433
ITALY: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 434
ITALY: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 435
ITALY: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 436
ITALY: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 437
ITALY: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 438
ITALY: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 439
ITALY: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 440
ITALY: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 441
ITALY: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 442
ITALY: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 443
ITALY: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 444
ITALY: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 445
ITALY: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 446
ITALY: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 447
ITALY: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 448
SPAIN: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 449
SPAIN: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 450
SPAIN: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 451
SPAIN: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 452
SPAIN: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 453
SPAIN: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 454
SPAIN: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 455
SPAIN: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 456
SPAIN: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 457
SPAIN: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 458
SPAIN: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 459
SPAIN: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 460
SPAIN: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 461
SPAIN: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 462
SPAIN: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 463
REST OF EUROPE: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 464
REST OF EUROPE: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 465
REST OF EUROPE: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 466
REST OF EUROPE: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 467
REST OF EUROPE: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 468
REST OF EUROPE: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 469
REST OF EUROPE: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 470
REST OF EUROPE: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 471
REST OF EUROPE: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 472
REST OF EUROPE: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 473
REST OF EUROPE: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 474
REST OF EUROPE: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 475
REST OF EUROPE: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 476
REST OF EUROPE: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 477
REST OF EUROPE: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 478
ASIA PACIFIC: MACROECONOMIC INDICATORS
 
 
 
 
TABLE 479
ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 480
ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 481
ASIA PACIFIC: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 482
ASIA PACIFIC: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 483
ASIA PACIFIC: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 484
ASIA PACIFIC: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 485
ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 486
ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 487
ASIA PACIFIC: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 488
SIA PACIFIC: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 489
ASIA PACIFIC: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 490
ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 491
ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 492
ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 493
ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 494
ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 495
CHINA: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 496
CHINA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 497
CHINA: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 498
CHINA: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 499
CHINA: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 500
CHINA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 501
CHINA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 502
CHINA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 503
CHINA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 504
CHINA: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 505
CHINA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 506
CHINA: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 507
CHINA: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 508
CHINA: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 509
CHINA: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 510
JAPAN: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 511
JAPAN: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 512
JAPAN: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 513
JAPAN: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE,2023–2030 (USD MILLION)
 
 
 
 
TABLE 514
JAPAN: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 515
JAPAN: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 516
JAPAN: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 517
JAPAN: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 518
JAPAN: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 519
JAPAN: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 520
JAPAN: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 521
JAPAN: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 522
JAPAN: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 523
JAPAN: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 524
JAPAN: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 525
INDIA: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 526
INDIA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 527
INDIA: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 528
INDIA: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 529
INDIA: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 530
INDIA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 531
INDIA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 532
INDIA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 533
INDIA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 534
INDIA: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 535
INDIA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 536
INDIA: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 537
INDIA: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 538
INDIA: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 539
INDIA: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 540
SOUTH KOREA: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 541
SOUTH KOREA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 542
SOUTH KOREA: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 543
SOUTH KOREA: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 544
SOUTH KOREA: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 545
SOUTH KOREA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 546
SOUTH KOREA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 547
SOUTH KOREA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 548
SOUTH KOREA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 549
SOUTH KOREA: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 550
SOUTH KOREA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 551
SOUTH KOREA: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 552
SOUTH KOREA: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 553
SOUTH KOREA: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 554
SOUTH KOREA: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 555
AUSTRALIA: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 556
AUSTRALIA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 557
AUSTRALIA: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 558
AUSTRALIA: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 559
AUSTRALIA: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 560
AUSTRALIA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 561
AUSTRALIA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 562
AUSTRALIA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 563
AUSTRALIA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 564
AUSTRALIA: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 565
AUSTRALIA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 566
AUSTRALIA: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 567
AUSTRALIA: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 568
AUSTRALIA: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 569
AUSTRALIA: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 570
REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 571
REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 572
REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 573
REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 574
REST OF ASIA PACIFIC: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 575
REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 576
REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 577
REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 578
REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 579
REST OF ASIA PACIFIC: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 580
REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 581
REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 582
REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 583
REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 584
REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 585
LATIN AMERICA: MACROECONOMIC INDICATORS
 
 
 
 
TABLE 586
LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 587
LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 588
LATIN AMERICA: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 589
LATIN AMERICA: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 590
LATIN AMERICA: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 591
LATIN AMERICA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 592
LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 593
LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 594
LATIN AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 595
LATIN AMERICA: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 596
LATIN AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 597
LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 598
LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 599
LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 600
LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 601
LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 602
BRAZIL: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 603
BRAZIL: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 604
BRAZIL: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 605
BRAZIL: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 606
BRAZIL: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 607
BRAZIL: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 608
BRAZIL: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 609
BRAZIL: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 610
BRAZIL: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 611
BRAZIL: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 612
BRAZIL: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 613
BRAZIL: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 614
BRAZIL: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 615
BRAZIL: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 616
BRAZIL: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 617
MEXICO: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 618
MEXICO: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 619
MEXICO: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 620
MEXICO: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 621
MEXICO: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 622
MEXICO: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 623
MEXICO: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 624
MEXICO: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 625
MEXICO: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 626
MEXICO: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 627
MEXICO: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 628
MEXICO: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 629
MEXICO: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 630
MEXICO: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 631
MEXICO: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 632
REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 633
REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 634
REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 635
REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 636
REST OF LATIN AMERICA: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 637
REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 638
REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 639
REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 640
REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 641
REST OF LATIN AMERICA: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 642
REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 643
REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 644
REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 645
REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 646
REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 647
MIDDLE EAST: MACROECONOMIC INDICATORS
 
 
 
 
TABLE 648
MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 649
MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 650
MIDDLE EAST: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 651
MIDDLE EAST: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 652
MIDDLE EAST: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 653
MIDDLE EAST: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE,2023–2030 (USD MILLION)
 
 
 
 
TABLE 654
MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 655
MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 656
MIDDLE EAST: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 657
MIDDLE EAST: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 658
MIDDLE EAST: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 659
MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 660
MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 661
MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 662
MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 663
MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 664
GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 665
GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 666
GCC COUNTRIES: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 667
GCC COUNTRIES: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 668
GCC COUNTRIES: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 669
GCC COUNTRIES: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 670
GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 671
GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 672
GCC COUNTRIES: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 673
GCC COUNTRIES: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 674
GCC COUNTRIES: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 675
GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 676
GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 677
GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 678
GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 679
GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 680
KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 681
KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 682
KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 683
KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 684
KINGDOM OF SAUDI ARABIA: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 685
KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 686
KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 687
KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 688
KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 689
KINGDOM OF SAUDI ARABIA: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 690
KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 691
KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 692
KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING MARKET,BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 693
KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 694
KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 695
UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 696
UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 697
UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 698
UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 699
UNITED ARAB EMIRATES: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 700
UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 701
UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 702
UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 703
UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 704
UNITED ARAB EMIRATES: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 705
UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 706
UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 707
UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 708
UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 709
UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 710
OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 711
OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 712
OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 713
OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 714
OTHER GCC COUNTRIES: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 715
OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 716
OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 717
OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 718
OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 719
OTHER GCC COUNTRIES: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 720
OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 721
OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 722
OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 723
OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 724
OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 725
REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 726
REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 727
REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 728
REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 729
REST OF MIDDLE EAST: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 730
REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 731
REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 732
REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 733
REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 734
REST OF MIDDLE EAST: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 735
REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 736
REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 737
REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 738
REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 739
REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 740
MACROECONOMIC OUTLOOK FOR AFRICA
 
 
 
 
TABLE 741
AFRICA: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 742
AFRICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 743
AFRICA: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 744
AFRICA: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 745
AFRICA: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 746
AFRICA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 747
AFRICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 748
AFRICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 749
AFRICA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 750
AFRICA: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 751
AFRICA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 752
AFRICA: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 753
AFRICA: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 754
AFRICA: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 755
AFRICA: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 756
SINGLE-CELL SEQUENCING MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, 2021–2025
 
 
 
 
TABLE 757
SINGLE-CELL SEQUENCING MARKET: DEGREE OF COMPETITION
 
 
 
 
TABLE 758
SINGLE-CELL SEQUENCING PRODUCT MARKET: REGION FOOTPRINT
 
 
 
 
TABLE 759
SINGLE-CELL SEQUENCING PRODUCT MARKET: PRODUCT TYPE FOOTPRINT
 
 
 
 
TABLE 760
SINGLE-CELL SEQUENCING PRODUCT MARKET: WORKFLOW FOOTPRINT
 
 
 
 
TABLE 761
SINGLE-CELL SEQUENCING PRODUCT MARKET: APPLICATION FOOTPRINT
 
 
 
 
TABLE 762
SINGLE-CELL SEQUENCING SERVICE MARKET: REGION FOOTPRINT
 
 
 
 
TABLE 763
SINGLE-CELL SEQUENCING SERVICE MARKET: SERVICE TYPE FOOTPRINT
 
 
 
 
TABLE 764
SINGLE-CELL SEQUENCING SERVICE MARKET: APPLICATION FOOTPRINT
 
 
 
 
TABLE 765
SINGLE-CELL SEQUENCING MARKET: DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
TABLE 766
SINGLE-CELL SEQUENCING MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
 
 
TABLE 767
SINGLE-CELL SEQUENCING MARKET: PRODUCT & SERVICE LAUNCHES, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 768
SINGLE-CELL SEQUENCING MARKET: DEALS, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 769
BD: COMPANY OVERVIEW
 
 
 
 
TABLE 770
BD: PRODUCTS OFFERED
 
 
 
 
TABLE 771
BD: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 772
BD: DEALS, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 773
THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 774
THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
 
 
 
 
TABLE 775
THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 776
DANAHER CORPORATION: COMPANY OVERVIEW
 
 
 
 
TABLE 777
DANAHER CORPORATION: PRODUCTS OFFERED
 
 
 
 
TABLE 778
DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 779
DANAHER CORPORATION: DEALS, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 780
10X GENOMICS: COMPANY OVERVIEW
 
 
 
 
TABLE 781
10X GENOMICS: PRODUCTS OFFERED
 
 
 
 
TABLE 782
10X GENOMICS: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 783
10X GENOMICS: DEALS, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 784
ILLUMINA, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 785
ILLUMINA, INC.: PRODUCTS OFFERED
 
 
 
 
TABLE 786
ILLUMINA, INC.: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 787
ILLUMINA, INC.: DEALS, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 788
MERCK KGAA: COMPANY OVERVIEW
 
 
 
 
TABLE 789
MERCK KGAA: PRODUCTS OFFERED
 
 
 
 
TABLE 790
QIAGEN N.V.: COMPANY OVERVIEW
 
 
 
 
TABLE 791
QIAGEN N.V.: PRODUCTS OFFERED
 
 
 
 
TABLE 792
BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 793
BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
 
 
 
 
TABLE 794
BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 795
TECAN TRADING AG: COMPANY OVERVIEW
 
 
 
 
TABLE 796
TECAN TRADING AG: PRODUCTS OFFERED
 
 
 
 
TABLE 797
TECAN TRADING AG: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 798
TECAN TRADING AG: DEALS, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 799
CYTEK BIOSCIENCES: COMPANY OVERVIEW
 
 
 
 
TABLE 800
CYTEK BIOSCIENCES: PRODUCTS OFFERED
 
 
 
 
TABLE 801
CYTEK BIOSCIENCES: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 802
CYTEK BIOSCIENCES: DEALS, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 803
CYTEK BIOSCIENCES: EXPANSIONS, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 804
TAKARA BIO INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 805
TAKARA BIO INC.: PRODUCTS OFFERED
 
 
 
 
TABLE 806
TAKARA BIO INC.: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 807
TAKARA BIO INC.: DEALS, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 808
BIO-TECHNE: COMPANY OVERVIEW
 
 
 
 
TABLE 809
BIO-TECHNE: PRODUCTS OFFERED
 
 
 
 
TABLE 810
BIO-TECHNE: DEALS, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 811
PACBIO: COMPANY OVERVIEW
 
 
 
 
TABLE 812
PACBIO: PRODUCTS OFFERED
 
 
 
 
TABLE 813
PACBIO: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 814
AZENTA US INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 815
AZENTA US INC.: SERVICES OFFERED
 
 
 
 
TABLE 816
NOVOGENE CO., LTD.: COMPANY OVERVIEW
 
 
 
 
TABLE 817
NOVOGENE CO., LTD.: SERVICES OFFERED
 
 
 
 
TABLE 818
NOVOGENE CO., LTD.: SERVICE LAUNCHES, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 819
NOVOGENE CO., LTD.: EXPANSIONS, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 820
IQVIA INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 821
IQVIA INC.: SERVICES OFFERED
 
 
 
 
TABLE 822
ALMAC GROUP: COMPANY OVERVIEW
 
 
 
 
TABLE 823
ALMAC GROUP: SERVICES OFFERED
 
 
 
 
TABLE 824
CEGAT GMBH: COMPANY OVERVIEW
 
 
 
 
TABLE 825
CEGAT GMBH: SERVICES OFFERED
 
 
 
 
TABLE 826
ACTIVE MOTIF: COMPANY OVERVIEW
 
 
 
 
TABLE 827
ACTIVE MOTIF: SERVICES OFFERED
 
 
 
 
TABLE 828
SINGLERON BIOTECHNOLOGIES: COMPANY OVERVIEW
 
 
 
 
TABLE 829
CELL MICROSYSTEMS: COMPANY OVERVIEW
 
 
 
 
TABLE 830
NANOCELLECT BIOMEDICAL: COMPANY OVERVIEW
 
 
 
 
TABLE 831
OXFORD NANOPORE TECHNOLOGIES PLC.: COMPANY OVERVIEW
 
 
 
 
TABLE 832
REVVITY: COMPANY OVERVIEW
 
 
 
 
TABLE 833
PARSE BIOSCIENCES: COMPANY OVERVIEW
 
 
 
 
TABLE 834
ULTIMA GENOMICS: COMPANY OVERVIEW
 
 
 
 
TABLE 835
MISSION BIO: BUSINESS OVERVIEW
 
 
 
 
TABLE 836
SINGLE CELL DISCOVERIES BV: COMPANY OVERVIEW
 
 
 
 
TABLE 837
ADMERA HEALTH: COMPANY OVERVIEW
 
 
 
 
TABLE 838
BGI: COMPANY OVERVIEW
 
 
 
 
TABLE 839
SIGNIOSBIO: COMPANY OVERVIEW
 
 
 
 
TABLE 840
MACROGEN CO., LTD.: COMPANY OVERVIEW
 
 
 
 
TABLE 841
LEXOGEN GMBH: COMPANY OVERVIEW
 
 
 
 
TABLE 842
DISCOVERY LIFE SCIENCES: COMPANY OVERVIEW
 
 
 
 
TABLE 843
CELLCARTA: COMPANY OVERVIEW
 
 
 
 
TABLE 844
SINGULOMICS CORPORATION: COMPANY OVERVIEW
 
 
 
 
TABLE 845
SEQMATIC LLC.: COMPANY OVERVIEW
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
FIGURE 1
SINGLE-CELL SEQUENCING MARKET: MARKETS & REGIONS COVERED
 
 
 
 
FIGURE 2
REGIONAL SEGMENTATION
 
 
 
 
FIGURE 3
YEARS CONSIDERED
 
 
 
 
FIGURE 4
RESEARCH DESIGN METHODOLOGY
 
 
 
 
FIGURE 5
SINGLE-CELL SEQUENCING MARKET: BREAKDOWN OF PRIMARY INTERVIEWS
 
 
 
 
FIGURE 6
SINGLE-CELL SEQUENCING MARKET SIZE ESTIMATION, 2024
 
 
 
 
FIGURE 7
GLOBAL MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH), 2024
 
 
 
 
FIGURE 8
ILLUSTRATIVE EXAMPLE OF 10X GENOMICS: REVENUE ANALYSIS (2024)
 
 
 
 
FIGURE 9
MARKET SIZE VALIDATION FROM PRIMARY SOURCES
 
 
 
 
FIGURE 10
SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
 
 
 
 
FIGURE 11
SINGLE-CELL SEQUENCING MARKET: CAGR PROJECTIONS, 2025−2030
 
 
 
 
FIGURE 12
SINGLE-CELL SEQUENCING MARKET: GROWTH ANALYSIS OF MARKET DYNAMICS
 
 
 
 
FIGURE 13
DATA TRIANGULATION METHODOLOGY
 
 
 
 
FIGURE 14
SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 15
SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 16
SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2024
 
 
 
 
FIGURE 17
SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 18
SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 19
SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 20
SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 21
SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 22
GEOGRAPHIC SNAPSHOT OF SINGLE-CELL SEQUENCING MARKET
 
 
 
 
FIGURE 23
ADVANCEMENTS IN SINGLE-CELL SEQUENCING TECHNOLOGIES TO PROPEL MARKET
 
 
 
 
FIGURE 24
PRODUCTS SEGMENT IN US ACCOUNTED FOR LARGEST MARKET SHARE IN 2024
 
 
 
 
FIGURE 25
CANCER RESEARCH APPLICATIONS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2024
 
 
 
 
FIGURE 26
PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2024
 
 
 
 
FIGURE 27
BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2024
 
 
 
 
FIGURE 28
ASIA PACIFIC REGION TO DOMINATE MARKET DURING FORECAST PERIOD
 
 
 
 
FIGURE 29
SINGLE-CELL SEQUENCING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
FIGURE 30
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
 
 
 
 
FIGURE 31
SINGLE-CELL SEQUENCING MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
FIGURE 32
SINGLE-CELL SEQUENCING MARKET: ECOSYSTEM ANALYSIS
 
 
 
 
FIGURE 33
PATENT APPLICATIONS IN SINGLE-CELL SEQUENCING MARKET, JANUARY 2014–DECEMBER 2024
 
 
 
 
FIGURE 34
SINGLE-CELL SEQUENCING MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
FIGURE 35
AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER, 2022–2024
 
 
 
 
FIGURE 36
AVERAGE SELLING PRICE OF PRODUCTS, BY REGION, 2024
 
 
 
 
FIGURE 37
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR SINGLE-CELL SEQUENCING PRODUCTS
 
 
 
 
FIGURE 38
KEY BUYING CRITERIA FOR END USERS
 
 
 
 
FIGURE 39
AI-USE CASES
 
 
 
 
FIGURE 40
NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET SNAPSHOT
 
 
 
 
FIGURE 41
NIH FUNDING FOR STEM CELL RESEARCH, 2015–2025
 
 
 
 
FIGURE 42
ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET SNAPSHOT
 
 
 
 
FIGURE 43
REVENUE ANALYSIS OF KEY PLAYERS IN SINGLE-CELL SEQUENCING MARKET, 2022–2024
 
 
 
 
FIGURE 44
MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024
 
 
 
 
FIGURE 45
SINGLE-CELL SEQUENCING PRODUCTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
 
 
 
 
FIGURE 46
SINGLE-CELL SEQUENCING PRODUCT MARKET: COMPANY FOOTPRINT
 
 
 
 
FIGURE 47
SINGLE-CELL SEQUENCING SERVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
 
 
 
 
FIGURE 48
SINGLE-CELL SEQUENCING SERVICES MARKET: COMPANY FOOTPRINT
 
 
 
 
FIGURE 49
SINGLE-CELL SEQUENCING MARKET: COMPANY EVALUATION MATRIX, (STARTUPS/SMES), 2024
 
 
 
 
FIGURE 50
EV/EBITDA OF KEY VENDORS
 
 
 
 
FIGURE 51
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
 
 
 
 
FIGURE 52
SINGLE-CELL SEQUENCING MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
 
 
 
 
FIGURE 53
BD: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 54
THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 55
DANAHER CORPORATION: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 56
10X GENOMICS: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 57
ILLUMINA, INC.: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 58
MERCK KGAA: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 59
QIAGEN N.V.: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 60
BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 61
TECAN TRADING AG: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 62
CYTEK BIOSCIENCES: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 63
TAKARA BIO INC.: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 66
AZENTA US INC.: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 67
IQVIA INC.: COMPANY SNAPSHOT (2024)
 
 
 
 

Methodology

This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global single-cell sequencing market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single cell sequencing market. The secondary sources used for this study The secondary sources used for this study include the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), the International Clinical Cytometry Society (ICCS), the International Society for Advancement of Cytometry (ISAC), the National Institutes of Health (NIH), the Organisation for Economic Co-operation and Development (OECD), and the Society for Laboratory Automation and Screening (SLAS); Corporate and Regulatory Filings, Annual Reports, Sec Filings, Investor Presentations, and Financial Statements; Business Magazines & Research Journals; Press Releases, MarketsandMarkets Analysis. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global single-cell sequencing market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (personnel from, pharmaceutical & and biotechnology companies, hospitals & diagnostic laboratories, academic & research institutes, and contract research organization) and supply side (C-level and D-level executives, product managers, and marketing and sales managers of key manufacturers, distributors, and channel partners, among others, across six major regions—North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. Approximately 70% of primary interviews were conducted with supply-side representatives, while demand-side participants accounted for the remaining share. This preliminary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

Single Cell Sequencing Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-cell sequencing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Single Cell Sequencing Market : Top-Down and Bottom-Up Approach

Single Cell Sequencing Market Top Down and Bottom Up Approach

Data Triangulation

After arriving at the overall market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.

Market Definition

Single-cell sequencing (SCS) is a genomic technology that allows researchers to study the genetic material of individual cells. Unlike traditional sequencing methods that analyze bulk cell populations, single-cell sequencing helps identify differences between individual cells, providing a clearer understanding of cell functions, disease mechanisms, and treatment responses. The scope of the single-cell sequencing market includes a wide range of products and services used across the entire single-cell workflow. This covers pre-sequencing instruments and consumables (such as cell isolation tools and library preparation kits), sequencing instruments and consumables, and software for analyzing single-cell data. The market also includes services provided by third parties across pre-sequencing, sequencing, and data analysis stages. The market also studies various sequencing types, including single-cell RNA sequencing (scRNA-seq), single-cell DNA sequencing (scDNA-seq), and single-cell ATAC sequencing (scATAC-seq), among others. These technologies are widely used in basic and translational research, drug discovery, and clinical applications, especially in cancer, neurological, and infectious diseases. End users of these solutions studied in the report include academic and research institutions, pharmaceutical and biotechnology companies, hospitals and diagnostic labs, and contract research organizations (CROs).

Stakeholders

  • Academic & Research Institutes
  • Single-cell Sequencing Assay & Reagent Manufacturers, Vendors, and Distributors
  • Contract Research Organizations (CROs)
  • Single-cell Sequencing Service & Software Providers
  • Diagnostics Companies
  • Market Research & Consulting Firms
  • Pharmaceutical & Biotechnology Companies
  • Regulatory Agencies
  • Venture Capitalists
  • Government organizations
  • Contract Development & Manufacturing Organizations (CDMOs)
  • Hospitals and Diagnostic Laboratories

Report Objectives

  • To define, describe, and forecast the global single-cell sequencing market based on offering, product type, product workflow, product end user, service type, service end user, sequencing type, application, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to six central regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
  • To profile the key players in the global single-cell sequencing market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments such as acquisitions, product launches & approvals, expansions, agreements, partnerships, and collaborations in the single-cell sequencing market
  • To benchmark players in the single-cell sequencing market using the “Company Evaluation Matrix” framework, which analyzes market players based on various parameters, including product portfolio, geographic reach, and market share

Available Customizations

With the given market data, MarketsandMarkets offers customizations to meet the company’s needs. The following customization options are available for the report:

Geographical Analysis

  • Further breakdown of the Rest of Europe’s single-cell sequencing market, by country
  • Further breakdown of the Rest of Asia Pacific’s single-cell sequencing market, by country
  • Further breakdown of the Rest of Latin America’s single-cell sequencing market, by country
  • Further breakdown of the Rest of the Middle East’s single-cell sequencing market, by country

Company Information

  • Detailed analysis and profiling of additional market players (up to five)

Segment Analysis

  • Further breakdown of the other technologies into subsegments
  • Cross-segment analysis

 

Key Questions Addressed by the Report

What are the opportunities for growth in the single-cell sequencing industry?

The growing adoption of single-cell sequencing technologies for clinical and diagnostic applications presents significant growth opportunities for the single-cell sequencing market.

Which instrument segment dominated the single-cell sequencing market in 2024?

In 2024, the pre-sequencing instruments segment accounted for the largest share within the single-cell sequencing instruments market.

Which single-cell sequencing-related offerings are expected to grow most during the forecast period?

Services related to single-cell sequencing are expected to witness the highest growth during the forecast period.

Which application segment held the largest share in the single-cell sequencing market?

The research application segment accounted for the largest share of the single-cell sequencing market in 2024.

What is the market size for the single-cell sequencing market in 2024?

The global single-cell sequencing market is valued at USD 1.89 billion in 2024.

TABLE OF CONTENTS

METHODOLOGY

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Single Cell Sequencing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request
Forbes

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Single Cell Sequencing Market

DMCA.com Protection Status